Esperion Therapeutics | ESPR - 员工总数

金融业

USD

USD 462.53M

现金及等价物

USD 156.16M

USD 27.85M

USD 459.46M

USD 300.36M

USD 262.92M

股息收益率

0

USD 85.23M

USD -9.93M

240

EPS每股收益

USD 0.26

股本和储备

USD -307.93M

USD 140.59M

债务利息支出

USD 22.64M

USD -0.15

USD 457.65M

USD 584.8M

USD 61.83M

USD 83.21M

USD 85.23M

普通股股本

USD 245.22M

129.79

USD 63.67M

USD 168.45M

销售和管理费用

USD 39.43M

USD 104.21M

贸易债权人

USD 68.41M

应收帐款人

USD 140.19M

	员工	更改		日
AbbVie	55K		5K	2024-12
Alnylam Pharmaceuticals	2.23K		130	2024-12
Alterity Therapeutics Limited	AUD 12		1	2022-06
Amarin	275		90	2023-12
Amgen	28K		1.3K	2024-12
Biogen	7.6K		35	2024-12
BioMarin Pharmaceutical	3.04K		361	2024-12
Cipla	30.31K		2.55K	2025-12
CSL	USD 32.06K		1.67K	2025-12
Cytokinetics	498		75	2024-12
Daiichi Sankyo	19.76K		1.04K	2025-12
Eli Lilly	47K		4K	2024-12
Esperion Therapeutics	240		41	2023-12
Geron	229		88	2024-12
Grifols	EUR 23.83K		89	2024-12
Halozyme Therapeutics	350		23	2024-12
Heron Therapeutics	126		77	2023-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Merck	75K		3K	2024-12
Minerva Neurosciences	9		0	2023-12
Moderna	5.8K		200	2024-12
Nektar Therapeutics	137		79	2023-12
Pfizer	81K		7K	2024-12
PTC Therapeutics	939		49	2024-12
Puma Biotechnology	185		7	2023-12
Regeneron Pharmaceuticals	13.45K		1.6K	2023-12
Sanofi	84.59K		3.41K	2024-12
Sarepta Therapeutics	1.37K		58	2024-12
United Therapeutics	1.3K		137	2024-12
Vanda Pharmaceuticals	203		87	2023-12